Latest Artia Global Partners LP Stock Portfolio

$499Million– No. of Holdings #48

Artia Global Partners LP Performance:

2026 Q1: -6.18%YTD: -6.18%2025: 43.83%

Performance for 2026 Q1 is -6.18%, and YTD is -6.18%, and 2025 is 43.83%.

About Artia Global Partners LP and 13F Hedge Fund Stock Holdings

On 2026-05-15, the fund reported it's updated stock portfolio. In the 13F Holdings report, Artia Global Partners LP reported an equity portfolio of $499.4 Millions as of 31 Mar, 2026.

The top stock holdings of Artia Global Partners LP are INSM, , LLY. The fund has invested 29.7% of it's portfolio in INSMED INC and 13.4% of portfolio in ABIVAX SA.

The fund managers got completely rid off PROSHARES TR II (AGQ), UNIQURE NV (QURE) and ASTRAZENECA PLC (AZN) stocks. They significantly reduced their stock positions in SOLENO THERAPEUTICS INC (SLNO), VIKING THERAPEUTICS INC (VKTX) and ARGENX SE (ARGX). Artia Global Partners LP opened new stock positions in ASTRAZENECA PLC, MERCK & CO INC (MRK) and TERNS PHARMACEUTICALS INC (TERN). The fund showed a lot of confidence in some stocks as they added substantially to XENON PHARMACEUTICALS INC (XENE), BELITE BIO INC (BLTE) and BRIGHTSPRING HEALTH SVCS INC.

Artia Global Partners LP Equity Portfolio Value

Last Reported on: 15 May, 2026

Artia Global Partners LP Annual Return Estimates Vs S&P 500

Our best estimate is that Artia Global Partners LP made a return of -6.18% in the last quarter. In trailing 12 months, it's portfolio return was 25.32%.

Performance
S&P 500

New Buys

Ticker	$ Bought
astrazeneca plc	18,810,100
alumis inc	7,160,760
merck & co inc	5,617,540
terns pharmaceuticals inc	5,525,060
johnson & johnson	5,524,340
biogen inc	3,380,060
edgewise therapeutics inc	2,063,250
cytokinetics inc	1,074,330

New stocks bought by Artia Global Partners LP

Additions

Ticker	% Inc.
xenon pharmaceuticals inc	62.5
belite bio inc	38.91
brightspring health svcs inc	29.33
celcuity inc	20.74
revolution medicines inc	19.96
bright minds biosciences inc	14.97

Additions to existing portfolio by Artia Global Partners LP

Reductions

Ticker	% Reduced
soleno therapeutics inc	-87.17
viking therapeutics inc	-74.88
argenx se	-54.03
nuvalent inc	-39.51
avalo therapeutics inc	-30.31
eli lilly & co	-24.32
dianthus therapeutics inc	-20.53
insmed inc	-17.58

Artia Global Partners LP reduced stake in above stock

Sold off

Ticker	$ Sold
uniqure nv	-24,493,300
ventyx biosciences inc	-6,284,720
proshares tr ii	-30,098,400
astrazeneca plc	-17,535,800
ocular therapeutix inc	-1,712,480
cidara therapeutics inc	-15,644,300
upstream bio inc	-1,863,930
avidity biosciences inc	-4,335,010

Artia Global Partners LP got rid off the above stocks

Sector Distribution

Artia Global Partners LP has about 64% of it's holdings in Healthcare sector.

Healthcare
Others

Sector	%
Healthcare	64
Others	36

Market Cap. Distribution

Artia Global Partners LP has about 49.1% of it's portfolio invested in the large-cap and mega-cap stocks.

LARGE-CAP
UNALLOCATED
MEGA-CAP
SMALL-CAP
MID-CAP

Category	%
LARGE-CAP	39
UNALLOCATED	36
MEGA-CAP	10.1
SMALL-CAP	7.1
MID-CAP	6.7

Stocks belong to which Index?

About 58% of the stocks held by Artia Global Partners LP either belong to S&P 500 or RUSSELL 2000 index.

RUSSELL 2000
Others
S&P 500

Index	%
RUSSELL 2000	45.6
Others	41.9
S&P 500	12.4

Top 5 Winners (%)		%
	dianthus therapeutics inc	93.0 %
KOD	kodiak sciences inc	36.3 %
TENX	tenax therapeutics inc	31.2 %
ROIV	roivant sciences ltd	27.6 %
XENE	xenon pharmaceuticals inc	22.7 %

Top 5 Winners ($)		$
	dianthus therapeutics inc	7.9 M
RVMD	revolution medicines inc	2.0 M
DGX	quest diagnostics inc	0.9 M
ROIV	roivant sciences ltd	0.8 M
XENE	xenon pharmaceuticals inc	0.7 M

Top 5 Losers (%)		%
PEPG	pepgen inc	-72.8 %
EYPT	eyepoint inc	-29.4 %
PALI	palisade bio inc	-25.5 %
	mineralys therapeutics inc	-25.4 %
TVTX	travere therapeutics inc	-22.3 %

Top 5 Losers ($)		$
	abivax sa	-14.1 M
INSM	insmed inc	-10.6 M
LLY	eli lilly & co	-6.9 M
ARGX	argenx se	-5.2 M
EYPT	eyepoint inc	-4.1 M

Artia Global Partners LP Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Artia Global Partners LP

Artia Global Partners LP has 48 stocks in it's portfolio. About 73.7% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. was the most profitable stock for Artia Global Partners LP last quarter.

Last Reported on: 15 May, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change	Options
ABBV	abbvie inc	0.63	14,500	3,153,600	unchanged	0.00

AGQ	proshares tr ii	0.00	0.00	0.00	sold off	-100	put

ALNY	alnylam pharmaceuticals inc	0.00	0.00	0.00	sold off	-100

ARGX	argenx se	4.35	29,739	21,716,900	reduced	-54.03

ASND	ascendis pharma a/s	0.81	17,740	4,057,670	unchanged	0.00

AVTX	avalo therapeutics inc	0.09	28,970	432,522	reduced	-30.31

AZN	astrazeneca plc	0.00	0.00	0.00	sold off	-100

BBIO	bridgebio pharma inc	0.30	20,400	1,514,900	unchanged	0.00

BIIB	biogen inc	0.68	18,437	3,380,060	new

BLTE	belite bio inc	0.80	24,989	3,984,250	added	38.91

CDTX	cidara therapeutics inc	0.00	0.00	0.00	sold off	-100

CELC	celcuity inc	0.36	15,576	1,777,840	added	20.74

CYTK	cytokinetics inc	0.22	16,300	1,074,330	new

DGX	quest diagnostics inc	1.60	40,817	7,999,320	unchanged	0.00

DRUG	bright minds biosciences inc	0.56	38,407	2,802,560	added	14.97

EWTX	edgewise therapeutics inc	0.41	65,500	2,063,250	new

EYPT	eyepoint inc	1.98	767,098	9,887,890	unchanged	0.00

INSM	insmed inc	29.74	908,412	148,544,000	reduced	-17.58

IONS	ionis pharmaceuticals inc	2.17	144,376	10,841,200	unchanged	0.00

JNJ	johnson & johnson	1.11	22,600	5,524,340	new